Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Invex Therapeutics Ltd. ( (AU:IXC) ) just unveiled an update.
Invex Therapeutics Ltd. has announced the appointment of Mr. Simon Llewellyn Owen as a new director, effective November 10, 2025. The announcement indicates that Mr. Owen currently holds no relevant interests in securities, which may suggest a fresh perspective in his role, potentially impacting the company’s strategic direction and stakeholder interests.
More about Invex Therapeutics Ltd.
Invex Therapeutics Ltd. operates in the biotechnology industry, focusing on the development of innovative therapies for unmet medical needs.
Average Trading Volume: 67,890
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$8.64M
Find detailed analytics on IXC stock on TipRanks’ Stock Analysis page.